Last 12 months
Inside the activity.
0 purchase rows · 414 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 47 |
| Jan 2026 | 0 | 20 |
| Feb 2026 | 0 | 19 |
| Mar 2026 | 0 | 35 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 44 |
| Jun 2026 | 0 | 45 |
| Jul 2026 | 0 | 99 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 38 |
| Oct 2026 | 0 | 9 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2025 Filed Jul 25, 2025 21:36 UTC |
Dageville BenoitDirector · President of Products
|
SaleCommon Stock | 25,000 | $214.63 | $5,365,825.00 |
DisclosureSEC source: 0001640147-25-000169 · wk-form4_1753479378.xml · nonDerivative · entry 4 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,325 F1 · kind: The exercises, sales, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $214.510 to $215.500, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 21:36 UTC |
Dageville BenoitDirector · President of Products
|
Exercise / conversionCommon Stock | 7,073 | $13.48 | $95,344.04 |
DisclosureSEC source: 0001640147-25-000169 · wk-form4_1753479378.xml · nonDerivative · entry 3 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises, sales, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 21:36 UTC |
Dageville BenoitDirector · President of Products
|
Exercise / conversionCommon Stock | 17,927 | $0.74 | $13,265.98 |
DisclosureSEC source: 0001640147-25-000169 · wk-form4_1753479378.xml · nonDerivative · entry 2 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises, sales, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 21:36 UTC |
Dageville BenoitDirector · President of Products
|
GiftCommon Stock | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000169 · wk-form4_1753479378.xml · nonDerivative · entry 1 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Indirect · Trust Disclosed balance after: 3,170,930 F1 · kind: The exercises, sales, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F2 · ownership.nature: The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 20:33 UTC |
Dageville BenoitDirector · President of Products
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001640147-25-000168 · wk-form4_1752265983.xml · derivative · entry 6 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 394,863 Underlying: Common Stock · 25,000 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise, sale, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F6 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 20:33 UTC |
Dageville BenoitDirector · President of Products
|
GiftCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000168 · wk-form4_1752265983.xml · nonDerivative · entry 3 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Indirect · Trust Disclosed balance after: 3,176,555 F1 · kind: The exercise, sale, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F3 · ownership.nature: The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 20:33 UTC |
Dageville BenoitDirector · President of Products
|
SaleCommon Stock | 25,000 | $221.83 | $5,545,750.00 |
DisclosureSEC source: 0001640147-25-000168 · wk-form4_1752265983.xml · nonDerivative · entry 2 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,325 F1 · kind: The exercise, sale, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 20:33 UTC |
Dageville BenoitDirector · President of Products
|
Exercise / conversionCommon Stock | 25,000 | $0.74 | $18,500.00 |
DisclosureSEC source: 0001640147-25-000168 · wk-form4_1752265983.xml · nonDerivative · entry 1 Dageville Benoit · CIK 0001821737 · Director · President of Products 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise, sale, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,483 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · derivative · entry 23 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,061,493 Underlying: Common Stock · 100,483 shares Expires 2029-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F22 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 2,732 | $226.02 | $617,494.84 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 14 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,507 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F14 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $225.980 to $226.050, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 17,172 | $225.25 | $3,867,941.48 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 13 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,239 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F13 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $224.980 to $225.725, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 26,403 | $224.63 | $5,930,773.88 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 12 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,411 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F12 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $223.980 to $224.970, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 14,399 | $223.18 | $3,213,583.22 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 11 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,814 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F11 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $222.955 to $223.570, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 23,292 | $222.56 | $5,183,914.10 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 10 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,213 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F10 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.950 to $222.925, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 16,485 | $221.38 | $3,649,432.82 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 9 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 249,505 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F9 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $220.950 to $221.910, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
Exercise / conversionCommon Stock | 100,483 | $8.88 | $892,289.04 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 8 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 840 | $221.47 | $186,033.96 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 7 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust (WWS-21) Disclosed balance after: 36,956 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 840 | $221.47 | $186,033.96 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 6 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust (LES-21) Disclosed balance after: 36,956 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 840 | $221.47 | $186,033.96 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 5 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust (ESS-21) Disclosed balance after: 36,956 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 840 | $221.47 | $186,033.96 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 4 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust (AMS-21) Disclosed balance after: 36,956 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 12,973 | $221.47 | $2,873,117.34 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 3 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Ltd Partnership Disclosed balance after: 570,796 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 34,005 | $221.47 | $7,531,053.35 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 2 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust (Rev Tr) Disclosed balance after: 1,496,205 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 23:35 UTC |
Speiser Michael LDirector
|
SaleCommon Stock | 403 | $221.47 | $89,252.01 |
DisclosureSEC source: 0001640147-25-000164 · wk-form4_1751931348.xml · nonDerivative · entry 1 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,539 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.250 to $222.205, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 323,713 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · derivative · entry 22 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,161,976 Underlying: Common Stock · 323,713 shares Expires 2029-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F22 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 36,414 | $225.62 | $8,215,581.02 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 7 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,507 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F8 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $225.400 to $225.860, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 71,715 | $224.92 | $16,129,994.37 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 6 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,921 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $224.400 to $225.360, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 30,089 | $223.73 | $6,731,781.88 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 5 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,636 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $223.405 to $224.320, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 48,004 | $222.71 | $10,691,114.85 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 4 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 303,725 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $222.375 to $223.350, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 111,696 | $221.83 | $24,777,747.07 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 3 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 351,729 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.380 to $222.370, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 25,795 | $221.09 | $5,703,093.94 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 2 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 463,425 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $220.380 to $221.370, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:35 UTC |
Slootman FrankDirector
|
Exercise / conversionCommon Stock | 323,713 | $8.88 | $2,874,571.44 |
DisclosureSEC source: 0001640147-25-000166 · wk-form4_1752093348.xml · nonDerivative · entry 1 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 489,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 3, 2025 22:59 UTC |
Briggs TeresaDirector
|
SaleCommon Stock | 1,146 | $217.74 | $249,530.04 |
DisclosureSEC source: 0001640147-25-000151 · wk-form4_1751583581.xml · nonDerivative · entry 2 Briggs Teresa · CIK 0001767659 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,474 F3 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 178,949 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · derivative · entry 19 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,485,689 Underlying: Common Stock · 178,949 shares Expires 2029-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F18 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 47,583 | $222.08 | $10,566,994.73 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 10 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,507 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F10 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $221.605 to $222.440, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 104,723 | $221.21 | $23,166,193.72 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 9 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,090 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F9 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $220.605 to $221.600, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 8,395 | $220.08 | $1,847,580.00 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 8 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,813 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F8 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $219.500 to $220.495, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 18,248 | $219.01 | $3,996,439.74 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 7 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 326,208 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $218.490 to $219.420, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
Exercise / conversionCommon Stock | 178,949 | $8.88 | $1,589,067.12 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 6 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 344,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 22:59 UTC |
Briggs TeresaDirector
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000151 · wk-form4_1751583581.xml · nonDerivative · entry 1 Briggs Teresa · CIK 0001767659 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,620 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 19:00 UTC |
BURTON JEREMYDirector
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000152 · wk-form4_1751583621.xml · nonDerivative · entry 1 BURTON JEREMY · CIK 0001234281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 23:00 UTC |
GARRETT MARKDirector
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000153 · wk-form4_1751583646.xml · nonDerivative · entry 1 GARRETT MARK · CIK 0001246215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,801 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 23:01 UTC |
Kramer Kelly A.Director
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000154 · wk-form4_1751583676.xml · nonDerivative · entry 1 Kramer Kelly A. · CIK 0001629885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,801 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 23:05 UTC |
Speiser Michael LDirector
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000156 · wk-form4_1751583907.xml · nonDerivative · entry 1 Speiser Michael L · CIK 0001433644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,942 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 23:04 UTC |
MCLAUGHLIN MARK DDirector
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000155 · wk-form4_1751583867.xml · nonDerivative · entry 1 MCLAUGHLIN MARK D · CIK 0001309507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,352 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 23:05 UTC |
Ullal JayshreeDirector
|
GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001640147-25-000157 · wk-form4_1751583929.xml · nonDerivative · entry 1 Ullal Jayshree · CIK 0001605809 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,801 F1 · shares: The shares represent restricted stock units, which will vest in full on the earlier of (i) the date of the annual meeting of the Issuer's stockholders to be held in 2026 (or the date immediately prior to such meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), or (ii) the first anniversary of the date of grant; subject to the Reporting Person's continued service through such date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 187,815 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · derivative · entry 18 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,664,638 Underlying: Common Stock · 187,815 shares Expires 2029-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F18 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 1,037 | $218.11 | $226,182.14 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 5 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,507 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $218.100 to $218.120, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 44,800 | $217.34 | $9,736,697.60 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 4 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,544 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $217.030 to $217.960, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 100,917 | $216.58 | $21,856,402.03 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 3 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,344 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $216.030 to $217.025, inclusive. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 23:34 UTC |
Slootman FrankDirector
|
SaleCommon Stock | 41,061 | $215.60 | $8,852,669.48 |
DisclosureSEC source: 0001640147-25-000163 · wk-form4_1751931285.xml · nonDerivative · entry 2 Slootman Frank · CIK 0001402348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,261 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 26, 2025. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $215.025 to $216.020, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.